Journal of Cardiac Failure
Volume 13, Issue 6 , Pages 431-436 , August 2007

Outcomes Following Surgical Ventricular Restoration for Patients With Clinically Advanced Congestive Heart Failure (New York Heart Association Class IV)

Received 11 September 2006 ,Revised 8 March 2007 ,Accepted 13 March 2007.

References 

  1. Hunt S, Baker D, Chin M, Cinquegrani M, Feldman A, Francis G, et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee to revise the 1995 guidelines for the evaluation and management of heart failure). Circulation. 2001;104:2996–3007
  2. O'Connell J, Bristow M. Economic impact of heart failure in the United States: time for a different approach. J Heart Lung Transplant. 1993;13:S107–S112
  3. Roger V, Weston S, Redfield M, Hellerman-Homan J, Killian J, Yawn B, et al. Trends in heart failure incidence and survival in a community based population. JAMA. 2004;292:344–350
  4. O'Connor C, Velazquez E, Gardner L, Smith P, Newman M, Landolfo K, et al. Comparison of coronary artery bypass grafting versus medical therapy on long-term outcome in patients with ischemic cardiomyopathy (a 25-year experience from the duke cardiovascular disease databank). Am J Cardiol. 2002;90:101–107
  5. Rose E, Gelijns A, Moskowitz A, Heitjan D, Stevenson L, Dembitsky W, et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med. 2001;345:1435–1443
  6. Califf RM, Adams WJ, McKenna M, Gheorghiade M, Uretsky B, McNulty S, et al. A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: the Flolan International Randomized Survival Trial (FIRST). Am Heart J. 1997;134:44–54
  7. Purek L, Laule-Kilian K, Christ A, Klima T, Pfisterer M, Perruchoud A, et al. Coronary artery disease and outcome in acute congestive heart failure. Heart. 2006;92:598–602
  8. Bart B, Shaw L, McCants C, Fortin D, Lee K, Califf R, et al. Clinical determinants of mortality in patients with angiographically diagnosed ischemic or non-ischemic cardiomyopathy. J Am Coll Cardiol. 1997;30:1002–1008
  9. Campana C, Gavazzi A, Berzuini C, Larizza C, Marioni R, D'Armini A, et al. Predictors of prognosis in patients awaiting heart transplantation. J Heart Lung Trans. 1993;12:756–765
  10. Ponikowski P, Anker S, Chua T, Szelemej R, Piepoli M, Adamopoulos S, et al. Depressed heart rate variability as an independent predictor of death in chronic congestive heart failure secondary to ischemic or idiopathic cardiomyopathy. Am J Cardiol. 1997;79:1645–1650
  11. Dor V, Saab M, Coste P, Kornaszewska M, Montiglio F. Left ventricular aneurysm: a new surgical approach. Thorac Cardiovasc Surgeon. 1989;37:11–19
  12. Athanasuleas C, Buckberg G, Stanley A, Siler W, Dor V, DiDonato M, et al. Surgical ventricular restoration in the treatment of congestive heart failure due to post-infarction ventricular dilation. J Am Coll Cardiol. 2004;44:1439–1445
  13. Maxey T, Reece T, Ellman P, Butler P, Kern J, Tribble C, et al. Coronary artery bypass with ventricular restoration is superior to coronary artery bypass alone in patients with ischemic cardiomyopathy. J Thorac Cardiovasc Surg. 2004;127:428–434
  14. Mickleborough L, Merchant N, Ivanov J, Rao V, Carson S. Left ventricular reconstruction: early and late results. J Thorac Cardiovasc Surg. 2004;128:27–37
  15. DiDonato M, Toso A, Maioli M, Sabatier M, Stanley A, Dor V, et al. Intermediate survival and predictors of death after surgical ventricular restoration. Semin Thorac Cardiovasc Surg. 2001;13:468–475
  16. DiDonato M, Sabatier M, Montiglio F, Maioli M, Toso A, Fantini F, et al. Outcome of left ventricular aneurysmectomy with patch repair in patients with severely depressed pump function. Am J Cardiol. 1995;76:557–561
  17. Dor V, Sabatier M, Di Donato M, Montiglio F, Toso A, Maioli M. Efficacy of endoventricular patch plasty in large postinfarction akinetic scar and severe left ventricular dysfunction: Comparison with a series of large dyskinetic scar. J Thorac Cardiovasc Surg. 1998;116:50–59
  18. Patel N, Williams J, Barriero C, Bonde P, Waldron M, Chang D, et al. Surgical ventricular remodeling for multiterritory myocardial infarction: defining a new patient population. J Thorac Cardiovasc Surg. 2005;130:1698–1706
  19. Patel N, Barriero C, Williams J, Bonde P, Waldron M, Natori S, et al. Surgical ventricular remodeling for patients with clinically advanced congestive heart failure and severe left ventricular dysfunction. J Heart Lung Transplant. 2005;24:2202–2210
  20. Patel N, Williams J, Nwakanma L, Waldron M, Bluemke D, Conte J. Surgical ventricular restoration for advanced congestive heart failure: should pulmonary hypertension be a contraindication?. Ann Thorac Surg. 2006;82:879–888
  21. Di Donato M, Toso A, Dor V, Sabatier M, Barlett G, Menicanti L, et al. Surgical ventricular restoration improves mechanical intraventricular dyssynchrony in ischemic cardiomyopathy. Circulation. 2004;109:2536–2543
  22. Schenk S, McCarthy P, Starling R, Hoercher K, Hail M, Ootaki Y, et al. Neurohormonal response to left ventricular reconstruction surgery in ischemic cardiomyopathy. J Thorac Cardiovasc Surg. 2004;128:38–43
  23. Conte JV. Surgical ventricular restoration: techniques and outcomes. Congest Heart Fail. 2004;10:248–251
  24. The SOLVD Investigators . Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med. 1991;325:293–302
  25. The CONSENSUS Trial Study Group . Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med. 1987;316:1429–1435
  26. Pitt B, Segal R, Martinez F, Meurers G, Cowley A, Thomas I, et al. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE). Lancet. 1997;349:747–752
  27. MERIT-HF Study Group . Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet. 1999;353:2001–2007
  28. Pfeffer M, Swedberg K, Granger C, Held P, McMurray J, Michelson E, et al. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme. Lancet. 2003;362:759–766
  29. MacIntyre K, Capewell S, Stewart S, Chalmers J, Boyd J, Finlayson A, et al. Evidence of improving prognosis in heart failure: Trends in case fatality in 66,457 patients hospitalized between 1986 and 1995. Circulation. 2000;102:1126–1131
  30. Ahmed A, Aronow W, Fleg J. Higher New York Heart Association classes and increased mortality and hospitalization in patients with heart failure and preserved left ventricular function. Am Heart J. 2006;151:444–450
  31. Di Donato M, Frigiola A, Benhamouda M, Menicanti L. Safety and efficacy of surgical ventricular restoration in unstable patients with recent anterior myocardial infarction. Circulation. 2004;110:II-169–II-173
  32. Moore C, Nancheria S. Surgical ventricular restoration in end-stage ischemic cardiomyopathy patients. Heart Surg Forum. 2004;7:E420–E422
  33. Aguiar Ribeiro G, Antoniali F, Lopes M, Costa C, Albuquerque A, Franchini K. Left ventricular reconstruction brings benefit for patients with ischemic cardiomyopathy. J Card Fail. 2006;12:189–194
  34. Buckberg G. Questions and answers about the STICH trial: a different perspective. J Thorac Cardiovasc Surg. 2005;130:245–249
  35. Doenst T, Velasquez E, Beyersdorf F, Michler R, Menicanti L, Di Donato M, et al. To STICH or not to STICH: we know the answer, but do we understand the question?. J Thorac Cardiovasc Surg. 2005;129:246–249
  36. Joyce D, Loebe M, Noon G, McRee S, Southard R, Thompson L, et al. Revascularization and ventricular restoration in patients with ischemic heart failure: the STICH trial. Curr Opin Cardiol. 2003;18:454–457

 Presented at the 10th Annual Scientific Meeting of the Heart Failure Society of America; September 10–13, 2006; Seattle, Washington.Supported in part by the Mildred and Carmont Blitz Cardiac Research Fund. Dr. Williams and Dr. Weiss are Irene Piccinini Investigators in Cardiac Surgery. Dr. Nwakanma is a Hugh R. Sharp Cardiac Surgery Research Fellow. Mr. Patel is the 2005 Chase Medical Scholar for Surgical Ventricular Restoration. Dr Conte has received research support from Chase Medical Corporation.

PII: S1071-9164(07)00097-8

doi: 10.1016/j.cardfail.2007.03.006

Journal of Cardiac Failure
Volume 13, Issue 6 , Pages 431-436 , August 2007